Veterinary and Comparative Oncology

Article	Citations
Issue Information	31
Issue Information	29
Timely adjuvant chemotherapy improves outcome in dogs with non‐metastatic splenic hemangiosarcoma undergoing splenectomy	27
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma	19
Effects of a high‐protein, increased‐fibre, dry diet supplemented with omega‐3 fatty acids on quality of life in dogs undergoing chemotherapy	18
High lysyl oxidase expression is an indicator of poor prognosis in dogs with cutaneous mast cell tumours	17
Investigation of efficacy of two different chemotherapy protocols used in neoadjuvant chemotherapy in clinical stages II–IV canine malignant mammary tumours	17
Outcomes of 35 dogs with craniomaxillofacial osteosarcoma treated with stereotactic body radiation therapy	15
Ultrasound‐guided core needle biopsy in dogs with thyroid carcinoma	14
Treatment of feline intermediate to high‐grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017–2021)	14
Descriptive analysis of haemangiosarcoma occurrence in dogs enrolled in the Golden Retriever lifetime study	13
Dysregulated miRNAs in a canine model of haemangiosarcoma metastatic to the brain	13
Plasma cell‐free DNA in canine lymphoma patients as a novel material for genotyping	13
Pre‐operative neoadjuvant vinblastine‐prednisolone in canine mast cell tumours: A single‐centre retrospective cohort study	12
Outcome of dogs treated with chemotherapy for mesothelioma: A retrospective clinical study on 40 cases and a literature review	12
Dose and Duration of Upfront Steroid Administration Have no Prognostic Impact in Dogs With Multicentric Diffuse Large B‐Cell Lymphoma	12
Combining radiation therapy with zoledronate for the treatment of osteo‐invasive feline oral squamous cell carcinoma	11
Blood biomarkers for canine cancer, from human to veterinary oncology	11
Prognostic Significance of Tumour Infiltrating Lymphocytes in Canine Oral Malignant Melanoma Treated With Anti‐Programmed Cell Death Ligand 1 ( PD ‐	11
	10
Efficacy and toxicity of carboplatin in the treatment of macroscopic mesenchymal neoplasia in dogs	10
Issue Information	10
Issue Information	10
Issue Information	10
Prognostic Value of a Histopathological Scoring System and the Ki67 Proliferation Index in Dogs With Phaeochromocytoma	10

Issue Information	10
Polarisation Sensitive Optical Coherence Tomography Image Characteristics for Gastrointestinal Tumours and Normal Tissues at Surgical Margins in Dogs	10
Author Index	10
	9
Corrigendum	9
Immunophenotyping and Mutation Analysis of Canine Intestinal T‐Cell Lymphoma: A Comparative Pathological Study of Human Enteropathy‐Associated T‐Cell Lymphoma	9
	9
Effects of Lipophilic Statins on Cell Viability and Tissue Factor Expression in Canine Haemangiosarcoma Cells	9
Issue Information	9
Chronic adrenergic stress and generation of myeloid‐derived suppressor cells: Implications for cancer immunotherapy in dogs	9
Use of Cystourethroscopy to Define the Gross Tumour Volume in Radiation Treatment Planning for Canine Genitourinary Carcinomas	9
Classification and Prognostication of B‐Cell and T‐Cell Multicentric Lymphoma in Dogs Using Serum MicroRNAs	8
Epidemiology of canine cutaneous round cell tumours on the canary archipelago in Spain	8
Issue Information	8
Frontal sinus carcinoma in forty‐one dogs (2001–2022)	8
Fractionated oral dosing and its effect on cyclophosphamide pharmacokinetics in dogs with high‐grade multicentric lymphoma	8
Author Index	8
	8
Spotlight on capecitabine for the treatment of unresectable or metastatic carcinoma of various origin: A retrospective study of 25 dogs	8
	8
Use of Lomustine and Prednisolone as First‐Line Treatment in Canine Multicentric Lymphoma	7
	7
Evaluation of the health‐related quality of life in dogs following intracranial meningioma resection using a specifically developed questionnaire	7
Serum Lactate Dehydrogenase as a Potential Prognostic Biomarker in Dogs With Appendicular Osteosarcoma	7
Blood Neutrophil‐to‐Lymphocyte Ratio as a Potential Prognostic Marker in Dogs ≤10 kg With Multicentric Lymphoma	7
DNA Methylation and Its Effects on TRIM29 Gene Expression in the Eq	7
Configuration of pathologic fractures in dogs with osteosarcoma following stereotactic body radiation therapy: A retrospective analysis	6
Quantification of circulating tumour cells over time in dogs with appendicular osteosarcoma	6
Favourable Prognostic Significance of HER2 Mutations in Canine Pulmonary Adenocarcinoma Following	6
Overactivation of Signal Transducer and Activator of Transcription 3 in Canine Hepatocellular Carcinoma and Its Prognostic Significance	6
Phase 1 Dose Escalation of Single‐Agent Mechlorethamine in Dogs With Lymphoma	6
Retrospective analysis of outcome and prognostic factors of subcutaneous mast cell tumours in dogs undergoing surgery with or without adjuvant treatment	6
Critical Questions in Genomic Diagnostics for Veterinary Oncology: What We Need to Know	6
Comparison of the anticancer effects of various statins on canine oral melanoma cells	6
Defining the relevance of surgical margins. Part two: Strategies to improve prediction of recurrence risk	6
Vinorelbine as a Rescue Treatment for Canine Histiocytic Sarcoma: A Multicentre Retrospective Study of 18 Dogs	6
	6
Description and efficacy of a response‐based “QUAD” cyclical hypofractionated palliative‐intent radiation protocol in dogs with macroscopic solid tumours: 108 cases	5
Identification of potential plasma protein biomarkers for feline pancreatic carcinoma by liquid chromatography tandem mass spectrometry	5
Isolation of Tumour‐Derived Extracellular Vesicles From the Plasma of Dogs Affected by Intracranial Tumours Showing Heterologous and Cross‐Species Tropism: A Pilot Study	5
Clinical Response to Imatinib Mesylate and Toxicity Profile in 35 Dogs With Mast Cell Tumours	5
Impact of 10% Dose Reductions and Duration of Treatment Delays in the Management of Chemotherapy‐Induced Neutropenia in Dogs Treated With Common Chemotherapy Protocols: A Single‐Centre Experience	5
Evaluating VEGFR2 as a Target for Anti‐Tumour Therapy in Canine Melanoma	5
Molecular Classification Based on the Gene Expression Profiles in Canine Histiocytic Sarcoma Cells	5
A Multi‐Institutional Retrospective Study of 21 Dogs Having Undergone Hypofractionated Radiotherapy for Adrenal Tumours (2017–2024)	5
	5
Rescue Protocols for Canine Non‐Indolent B Cell Lymphoma: A Systematic Review	5
Evaluation of serum interleukin 2 receptor and beta‐2‐microglobulin as prognostic factors for canine lymphoma: A pilot study	5
Stereotactic body radiation therapy as an alternative to adrenalectomy for the treatment of pheochromocytomas in 8 dogs	5
Sentinel lymph node mapping in canine mast cell tumours using a preoperative radiographic indirect lymphography: Technique description and results in 138 cases	4

Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF‐κB pathway in canine mammary carcinoma cells	4
Sentinel lymph node mapping with computed tomography lymphography for mast cell tumours and a comparison between regional and sentinel lymph node histological status: Sixty‐two cases	4
Cyclical 10‐day dosing of melphalan for canine multiple myeloma	4
Prognostic significance of CD25 expression in dogs with a noninvasive diagnosis of B‐cell lymphoma treated with CHOP chemotherapy	4
Mass spectrometric‐based assessment of the serum kappa to lambda immunoglobulin light chain ratio (κ:λ) in dogs with immunoglobulin secretory diseases	4
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma	4
Evaluating the relevance of surgical margins. Part one: The problems with current methodology	4
Correction to “ DNA Methylation and Its Effects on TRIM29 Gene Expression in the Equine Sarcoid Ti	4
Comparative Response of Canine and Human Osteosarcoma Tumour Cell Lines to Molecularly Targeted Anticancer Agents at Clinically Relevant Exposures With Analysis of Genomic Biomarkers	4
Clinical outcomes in cats with renal carcinoma undergoing nephrectomy: A retrospective study	4
Half‐Body Radiation Therapy Results in a Prolonged Progression‐Free Interval in Canine High‐Grade Lymphoma After First Remission	4
Proteasome Inhibitor–Induced Cytotoxic Mechanisms in Canine Pulmonary Adenocarcinoma Cell Lines	4
Sodium iodide symporter immunolabelling as a predictor of clinical iodide uptake in canine thyroid carcinoma: A preliminary study	4
Immunological Pre‐Metastatic Niche in Dogs With Naturally Occurring Osteosarcoma	4
Machine Learning‐Based Risk Prediction for Feline Mammary Tumours: A Comprehensive Epidemiological Analysis Using Multi‐Model Ensemble Approach	4
Correlation between computed tomography and histological evaluation of nodal metastasis in dogs with mast cell tumours	4
Issue Information	4
VCS abstract	4
Comprehensive Analysis of the Tumour Immune Microenvironment in Canine Urothelial Carcinoma Reveals Immunosuppressive Mechanisms Induced by the COX–Prostanoid Cascade	4
	3
Hotspot Exon 15 Mutations in BRAF Are Uncommon in Feline Tumours	3
VCS 2024 Abstracts	3
Expression of the hedgehog signalling pathway and the effect of inhibition at the level of smoothened in canine osteosarcoma cell lines	3
Issue Information	3
Retrospective study evaluating the efficacy of stereotactic body radiation therapy for the treatment of confirmed or suspected primary pulmonary carcinomas in dogs	3
Evaluation of the Amount of Compounded Chemotherapy Drugs: A Comparison Between Nine Compounding Pharmacies	3
Flow Cytometry for the Detection and Quantification of Mast Cells in Lymph Nodes: A Prospective Study in 64 Dogs With Mast Cell Tumour	3
Early‐Delayed Radiotoxicity Associated With Stereotactic Radiation Therapy Following a Daily 6 Gy × 5 (30 Gy) Protocol for Presumed Canine Intracranial Meningiomas	3
The animal's microbiome and cancer: A translational perspective	3
Do Pre‐Treatment Biopsy Characteristics Predict Early Tumour Progression in Feline Diffuse Large B Cell Nasal Lymphoma Treated With Radiotherapy?	3
Issue Information	3
Precision in Parsing: Evaluation of an Open‐Source Named Entity Recognizer (NER) in Veterinary Oncology	3
Correction to: Standardization of canine meningioma grading: Validation of new guidelines for reproducible histopathologic criteria	3
Outcome and Prognostic Factors of Dogs Treated for Infiltrative Lipoma Undergoing Radiation Therapy: A Retrospective Multi‐Institutional Study of 29 Cases	3
Serum level of apoptosis inhibitor of macrophage in dogs with histiocytic sarcoma and its association with the disease	3
One Health: Therapies Targeting Genetic Variants in Human and Canine Histiocytic and Dendritic Cell Sarcomas	3
Prognostic Impact of a Histologic Grading Scheme in Dogs Diagnosed With Rib Chondrosarcoma	3
Characterisation of Gene Expression in Canine Invasive Urothelial Carcinoma Using a NanoString‐Based Urine Assay	3
Cover Image	3
Vincristine Induced Adverse Effects in Lymphoma Bearing Dogs With Asymptomatic Neutropenia at the Time of Drug Administration	3
Prognostic Impact of CD206 + M2 ‐Like Macrophages in Canine Appendicular Osteosarcoma	3
Toosendanin‐induced apoptosis of CMT‐U27 is mediated through the mitochondrial apoptotic pathway	3
A retrospective study of canine oral extramedullary plasmacytoma over a 15‐year period (July 2004–July 2019): Treatment, histologic parameters and clinical outcomes	3
Thromboelastographic results and hypercoagulability in dogs with surgically treated hepatocellular adenoma and carcinoma: A Veterinary Society of Surgical Oncology prospective study	3
Neurological Recovery in 14 Cats With Epidural Lymphoma Treated With Chemotherapy	2
	2
Clinical Utility of Circulating Cell‐Free DNA as a Liquid Biopsy in Cats With Various Tumours	2
Surgical and oncologic outcomes in dogs with malignant peripheral nerve sheath tumours arising from the brachial or lumbosacral plexus	2
Patterns of nodal metastases, biological behaviour and prognosis of canine mast cell tumours of the pinna: A multi‐institutional retrospective study	2
Macrophage Colony Stimulating Factor (M‐CSF) and Interleukin‐34 (IL‐34) Expression in Canine Osteosarcoma in the Context of the Tumour Immune Microenvironment	2
Tolerability and Adverse Event Profile of Fixed Dose Rate Gemcitabine in Dogs With Neoplasia	2
	2
Safety and feasibility of short course pre‐operative radiation therapy followed by surgical excision for canine solid tumours	2
Comparison of Three Chemotherapy Protocols With Electrochemotherapy for the Treatment of Feline Cutaneous Squamous Cell Carcinoma	2
Long‐term survival of dogs with stage 4 oral malignant melanoma treated with anti‐canine PD‐1 therapeutic antibody: A follow‐up case report	2
	2
Effect of Changes in Canine Thyroid Cancer Terminology on Caregiver Anxiety Levels and Treatment Preferences in a Scenario‐Based Study	2
Impacts of Vincristine and Prednisolone Chemotherapy on the Canine Gut Microbiota in Dogs Undergoing Treatment for Lymphoma	2
Serum Symmetric Dimethylarginine as a Predictor of Toxicity of Carboplatin in Dogs	2
Molecular and Pathobiology of Canine Mammary Tumour: Defining a Translational Model for Human Breast Cancer	2
	2
Clinical Efficacy and Tolerability of Sorafenib in Dogs With Advanced Carcinomas	2
Whole Exome Sequencing of Feline Oral Squamous Cell Carcinoma Reveals Genomic Parallels With Human Head and Neck Squamous Cell Carcinoma	2
Impact of palliative‐intent radiotherapy with or without chemotherapy on lameness in flat coat retrievers with localised periarticular histiocytic sarcoma – a retrospective cohort, single institution	2
Establishment of a new cell line of canine inflammatory mammary cancer: IMC‐118	2
Risk factors influencing death prior to discharge in 302 dogs undergoing unilateral adrenalectomy for treatment of primary adrenal gland tumours	2
Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma	2
Issue Information	2
Lifetime prevalence of malignant and benign tumours in companion dogs: Cross‐sectional analysis of Dog Aging Project baseline survey	2
Immunohistochemical and transcriptomic characterization of T and myeloid cell infiltrates in canine malignant melanoma	2
Polarisation‐Sensitive Optical Coherence Tomography for Surgical Margin Evaluation and Diagnosis of Excised Canine Cutaneous and Subcutaneous Tumours	2
Issue Information	2
Investigation of a 4.3 Gy × 10‐Fraction Volumetric Modulated Arc Therapy Protocol for Canine Prostatic Carcinoma: A Normal Tissue Complication Probability Study	2
Calculation of dose intensity and comparison of published methods using a cohort of canine T‐cell lymphoma patients undergoing CHOP‐based chemotherapy	2
A multi‐institutional epidemiologic study evaluating environmental risk factors for feline oral squamous cell carcinoma	2
Sequence Diversity and Expression Profiles of T Cell Receptor Beta Chain Constant Genes TRBC1 and	2
Prognostic Impact of Mast Cell Infiltration Detected by Flow Cytometry on Excised Sentinel Lymph Nodes in Dogs With Newly Diagnosed Mast Cell Tumours	2
Genomic Evaluation of Canine Prostatic Carcinomas as a Model for the Human Disease: or ‘UC or not UC – that is the question’	1
A multi‐centre prospective evaluation of internet research habits among owners seeing a veterinary oncologist	1
Local tumour nanoparticle thermal therapy: A promising immunomodulatory treatment for canine cancer	1

Chemoresistance Cytological Score for Canine Transmissible Venereal Tumour: A Proposed System of Predicting Vincristine Resistance	1
Pilot study to evaluate isolation by size of circulating tumour cells in canine oral melanoma	1
Recurrence Rates for Mandibular Fibrosarcoma Associated With Mandibular Canal Invasion Following Mandibulectomy Procedures in Dogs	1
Issue Information	1
Retrospective Analysis of Survival and Adverse Effects Associated With Stereotactic Body Radiation Therapy in 12 Dogs With Hepatocellular Carcinoma	1
	1
	1
Hemangiosarcoma: A Systematic Review of Biomarkers in Diagnosis, Prognosis, and Therapeutic Strategies	1
Allogeneic peripheral blood haematopoietic stem cell transplantation for the treatment of dogs with high‐grade B‐cell lymphoma	1
Multi‐institutional retrospective study of canine foot pad malignant melanomas: 20 cases	1
Feline primary nonhematopoietic malignant liver tumours: A multicenter retrospective study (2000–2021)	1
The association between symmetric dimethylarginine concentrations and various neoplasms in dogs and cats	1
Tumour necrosis factor stimulated gene 6 intrinsically regulates PD‐L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment	1
Issue Information	1
Outcomes of Stereotactic Radiation Therapy Versus Fractionated Radiation Therapy in 44 Dogs With Pituitary Masses: A Multi‐Institutional Retrospective Study (2016–2022)	1
Expanding the Spectrum of Canine Diffuse Large B‐Cell Lymphoma Genetic Aberrations Through Whole Genome Sequencing Analysis	1
Issue Information	1
Evaluation of Decreased Kidney Function in Dogs Receiving Carboplatin: A Retrospective Cohort Study of 98 Dogs (2006–2024)	1
	1
Patterns of metastatic progression and association with clinical outcomes in canine osteosarcoma: A necropsy study of 83 dogs	1
Preoperative Computed Tomography Features as Predictors of Malignancy and Survival in Canine Adrenal Tumours	1
	1
Standardization of canine meningioma grading: Validation of new guidelines for reproducible histopathologic criteria	1
Editorial	1
Conventional fractionated radiotherapy outcomes for young dogs with nephroblastoma of the spinal cord: 5 cases	1
Cytokine‐Enhanced Vaccine as Surgery Adjuvant Treatment for Spontaneous Canine Melanoma: Comparison of Two Intralesional Procedures for Local Disease Control	1
Chemical Exposures, DNA Methylation and Whole Blood DNA Damage in Pet Golden Retrievers	1
Immunohistochemical Expression of Programmed Death‐Ligand 1 and Cytotoxic T‐Lymphocyte Antigen‐4 in Canine Cutaneous Mast Cell Tumours	1
Lymphotropic nanoparticle magnetic resonance imaging for diagnosing metastatic lymph nodes in dogs with malignant head and neck tumours	1
Transferrin Receptor‐1: Expression in Canine Mammary Tumours and In Vitro Therapeutic Applications	1
Comparison of Volumetric Modulated Arc Therapy and Fixed‐Field Intensity‐Modulated Radiotherapy for Canine Prostatic Carcinoma Using a 4.3 Gy × 10‐Fraction Protocol: A Dosimetric Planning Study	1
Evaluating the Impact of Elective Nodal Irradiation for Dogs With Oral Malignant Melanoma Undergoing Hypofractionated Radiotherapy	1
Outcome and Toxicity Profile of Stereotactic Body Radiation Therapy for Adrenal Tumours in Dogs	1
Tolerability Assessment of Orally Administered Paclitaxel With Encequidar in Dogs With Spontaneous Malignancy	1
Tissue Proteomics of Feline Mammary Carcinoma: Differences in Protein Profiles Among Histological Grades Using Liquid Chromatography–Tandem Mass Spectrometry	1
New molecular targets in canine hemangiosarcoma—Comparative review and future of the precision medicine	1
Urinary and household chemical exposures in pet dogs with urothelial cell carcinoma	1
Issue Information	1
Comparison of Morbidity Between Sentinel Lymph Node Biopsy and Elective Neck Dissection in Dogs With Head and Neck Malignancies	1